Literature DB >> 15157698

Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area.

T Bartsch1, M J Levy, Y E Knight, P J Goadsby.   

Abstract

The novel neuropeptides orexin A and B are selectively synthesised in the lateral and posterior hypothalamus and are involved in hypothalamic regulation of autonomic and neuroendocrine functions. Recent findings point also to a role in nociception. As the posterior hypothalamus is involved in the central modulation of nociception we studied the effects of hypocretin/orexin receptor activation in the posterior hypothalamic area (PH) of the rat on dural nociceptive input. Orexins were microinjected into the PH and the effects on responses of neurones in the caudal trigeminal nucleus studied. Injection of orexin A decreased the A- and C-fibre responses to dural electrical stimulation as well as spontaneous activity. Responses to noxious thermal stimulation of the facial skin were also decreased by orexin A. Injection of orexin B into the PH, however, elicited increased responses to dural stimulation in A- and C-fibre responses and resulted in increased spontaneous activity. Responses to facial thermal stimulation were also increased by orexin B. Control injection of saline into the PH had no significant effect. The results show a differential modulation of dural nociceptive input by orexin A and B receptor activation in the PH. The results support the role of the PH in the nociceptive processing of meningeal input. As both peptides are also involved in hypothalamic regulation of neuroendocrine and autonomic functions, orexinergic mechanisms in the PH may provide a link for endocrine and autonomic changes as well as nociceptive phenomena seen in primary headache disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157698     DOI: 10.1016/j.pain.2004.02.005

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  55 in total

Review 1.  Diencephalic and brainstem mechanisms in migraine.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

Review 2.  Deep brain stimulation in cluster headache: hypothalamus or midbrain tegmentum?

Authors:  Manjit S Matharu; Ludvic Zrinzo
Journal:  Curr Pain Headache Rep       Date:  2010-04

3.  Lateral Hypothalamic Stimulation Reduces Hyperalgesia Through Spinally Descending Orexin-A Neurons in Neuropathic Pain.

Authors:  Jacob Wardach; Monica Wagner; Younhee Jeong; Janean E Holden
Journal:  West J Nurs Res       Date:  2015-10-15       Impact factor: 1.967

Review 4.  The hypocretins/orexins: integrators of multiple physiological functions.

Authors:  Jingcheng Li; Zhian Hu; Luis de Lecea
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

5.  Hypothalamic regulation of headache and migraine.

Authors:  Arne May; Rami Burstein
Journal:  Cephalalgia       Date:  2019-08-29       Impact factor: 6.292

6.  Trigeminal autonomic cephalgias.

Authors:  Rafael Benoliel
Journal:  Br J Pain       Date:  2012-08

7.  The posterior hypothalamus exerts opposing effects on nociception via the A7 catecholamine cell group in rats.

Authors:  Y Jeong; J R Moes; M Wagner; J E Holden
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

Review 8.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

9.  Thermal nociception is decreased by hypocretin-1 and an adenosine A1 receptor agonist microinjected into the pontine reticular formation of Sprague Dawley rat.

Authors:  Sarah L Watson; Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  J Pain       Date:  2009-12-16       Impact factor: 5.820

Review 10.  [The trigemino-cervical complex. Integration of peripheral and central pain mechanisms in primary headache syndromes].

Authors:  V Busch; A Frese; T Bartsch
Journal:  Schmerz       Date:  2004-10       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.